ABOUT ACTA PHARMACEUTICA
ACTA PHARMACEUTICA (AP) is a quarterly journal of
CROATIAN PHARMACEUTICAL SOCIETY
SLOVENIAN PHARMACEUTICAL SOCIETY,
dealing with all branches of pharmaceutical and related sciences. It is an international, scientific, multidisciplinary journal, which brings articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also.
This is a peer-reviewed journal with fully open access and “early bird” platform. To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.
Acta Pharmaceutica has a printing run of 250 copies and it is partly supported by the Ministry of Science and Education of Republic of Croatia.
Subscription rate per volume (containing 4 issues) including surface postage is 100 Eur (from Vol. 55). Each issue costs 25 Eur. Payments should be made to the order of the Croatian Pharmaceutical Society, Masarykova 2, HR-10000 Zagreb, Croatia, through ZAGREBACKA BANKA d.d., Trg bana Josipa Jelačića 10, Zagreb, Croatia, account no. HR8923600001101367614 SWIFT ZABA HR 2X.
All submitted manuscripts should conform to generally accepted usage in composition of research papers. For technical requirements author should consult Instructions to authors and the recent issues.
AP is indexed in numerous world top international bibliographic bases, like Clarivate™ Web of Science Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. It is a Q2 journal (pharmaceutical sciences) according to SCImago with a steadily increasing Clarivate™ JIF value reaching 2.230 in 2020.
International Advisory Board
Rudolf Bauer (Graz), Atilla Hincal (Ankara), Ivan Jalšenjak (Zagreb), Hans E. Junginger (Marburg), Roman Kaliszan (Gdansk), M. Zahirul I. Khan (Melbourne), Peter Matyus (Budapest), Beatrice Perissutti (Trieste), Stane Srčič (Ljubljana)
Croatian Pharmaceutical Society
Masarykova 2, HR-10000 Zagreb, Croatia
from Faculty of Pharmacy and Biochemistry, University of Zagreb,
A. Kovacica 1, HR-10000 Zagreb, Croatia
Karmela Barišić, Mojca Kerec-Kos, Željka Vanić, Donatella Verbanac
Karmela Barišić (Zagreb)
Jelena Filipović-Grčić (Zagreb)
Mojca Kerec-Kos (Ljubljana)
Jasmina Lovrić (Zagreb)
Svjetlana Luterotti (Zagreb)
Željan Maleš (Zagreb)
Izidor Sosič (Ljubljana)
Željka Vanić (Zagreb)
Donatella Verbanac (Zagreb)
Branka Zorc (Zagreb)
Alenka Zvonar Pobirk